Alzamend Neuro, Inc. (ALZN)
NASDAQ: ALZN · Real-Time Price · USD
1.365
+0.145 (11.89%)
Jun 23, 2026, 2:18 PM EDT - Market open
Alzamend Neuro Market Cap
Alzamend Neuro has a market cap or net worth of $5.19 million as of June 23, 2026. Its market cap has increased by 79.12% in one year.
Market Cap
5.19M
Enterprise Value
2.23M
1-Year Change
79.12%
Ranking
Category
Stock Price
$1.37
Market Cap Chart
Since the IPO on June 15, 2021, Alzamend Neuro's market cap has decreased from $1.15B to $5.19M, a decrease of -99.55%. That is a compound annual growth rate of -65.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 23, 2026 | 5.19M | -24.94% |
| Dec 31, 2025 | 6.92M | 9.79% |
| Dec 31, 2024 | 6.30M | -0.56% |
| Dec 29, 2023 | 6.34M | -88.37% |
| Dec 30, 2022 | 54.47M | -67.73% |
| Dec 31, 2021 | 168.82M | -85.28% |
| Jun 15, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Mustang Bio | 5.11M |
| Liminatus Pharma | 5.09M |
| Dermata Therapeutics | 4.95M |
| Enveric Biosciences | 4.90M |
| CollPlant Biotechnologies | 4.87M |
| TransCode Therapeutics | 4.75M |
| GeoVax Labs | 4.58M |
| 60 Degrees Pharmaceuticals | 4.49M |